L
LENSAR LLC
We are the leader in next-generation femtosecond laser technology for refractive cataract surgery. Our mission is to take the time to understand the needs of surgeons and their patients so that we can innovate our technology to ensure we meet their dynamic needs. In only 2 years, we provided our surgeons with 6 software updates to guide more precise astigmatism management and improved refractive outcomes. We are able to deliver the best medicine to their patients and better business for their practices.
Country/Area ：United States
Company Email ：info@lensar.com
Industry ：Health CareMedical Devices & EquipmentManufacturingTools & HardwareMachinery
Company address ：2800 Discovery Dr, Orlando, Florida, 32826, United States
Company website ：*****
Company phone ：(888) 536-7271
Established ：2004
Company Revenue ：$35,400,000
Number of employees ：110
SIC Code ：38384
NAICS Code ：33333
Main Products ：LENSAR Laser SystemALLY System
Company News
LENSAR Reports Third Quarter 2023 Results and Provides Business Update
Nov 9, 2023
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced financial results for the quarter ended September 30, 2023 and provided an update on key operational initiatives. “We have seen continued strength in our business in the third quarter, with total revenue up 26% and U.S. procedure volume increasing 16% year-over-year. This stron
Nov 9, 2023
LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023Nov 2, 2023
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced that the Company’s third quarter 2023 financial results will be released before market open on Thursday, November 9, 2023. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Thursday, November 9, 2023 to discuss the financial results and recent corpora
Nov 2, 2023Several Insiders Invested In LENSAR Flagging Positive NewsAug 18, 2023
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
Aug 18, 2023LENSAR, Inc. (LNSR) Q2 2023 Earnings Call TranscriptAug 11, 2023
LENSAR, Inc. (NASDAQ:NASDAQ:LNSR) Q2 2023 Earnings Conference Call August 9, 2023 8:30 AM ETCompany ParticipantsCameron Radinovic – Burns McClellanNick Curtis – Chief Executive OfficerTom...
Aug 11, 2023LENSAR Reports Second Quarter 2023 Results and Provides Business UpdateAug 9, 2023
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2023 and provided an update on key operational initiatives. “The second quarter was a strong quarter for us, which saw a substantive number of ALLY placements that we had been working on coming to fruition, resulting in a steady
Aug 9, 2023Web Summary
Q1: What is the address of LENSAR LLC's Medical Advisory Board?
A1: The text does not explicitly provide the physical address of LENSAR LLC, but it mentions that its industry-leading innovation is guided by the experience and influence of its prestigious Medical Advisory Board.
Q2: What products or services are associated with LENSAR LLC?
A2: Although the provided content primarily focuses on the company's Medical Advisory Board, it does mention that LENSAR LLC offers various products and supplies related to ophthalmology, such as certificates, electronic user manuals, and clinical training materials.
Q3: In which industry is LENSAR LLC operating?
A3: Based on the information provided, it appears that LENSAR LLC operates in the medical device industry, specifically in the field of ophthalmology.
Q4: What services does LENSAR LLC offer to its patients?
A4: The text mentions that LENSAR LLC provides support for patients through various channels, including a contact us page and marketing portal. However, it does not provide detailed information on specific services offered to patients.
Q5: How can one contact LENSAR LLC's customer support or investor relations department?
A5: According to the provided content, investors can contact LENSAR LLC through its Investor Relations section, while customers can reach out to them through the CONTACT US page. However, no phone number is explicitly mentioned.
Q6: What is the composition of LENSAR LLC's Medical Advisory Board?
A6: The text lists 8 members of LENSAR LLC's Medical Advisory Board, including Carlos Buznego, MD; Alan Faulkner, MD; Mitchell A Jackson, MD; Mark Packer, MD, FACS, CPI; and others.
Q7: What is the background and expertise of Dr. Carlos Buznego?
A7: Dr. Carlos Buznego is a Miami-based board-certified ophthalmologist with extensive experience in LASIK, laser cataract, and micro-invasive glaucoma surgery. He has also served as an active staff member at several hospitals and universities.
Q8: What are some notable achievements of Dr. Alan Faulkner?
A8: Dr. Alan Faulkner is a Hawaii-based board-certified ophthalmologist who has been recognized for his expertise in refractive cataract procedures. He has received numerous awards, including being named a Castle Connolly Top Doctor and a Top Doctor in Hawaii by Honolulu Magazine.
Q9: What are some notable achievements of Dr. Mitchell A Jackson?
A9: Dr. Mitchell A Jackson is a board-certified ophthalmologist who has been recognized for his expertise in cataract and refractive surgery. He has received several awards, including the PS250 Premier Surgeon list, OSN300 Refractive Surgeon list, and the 2018 Annual Millennial Award.
Q10: What is LENSAR LLC's relationship with Cassini Technologies?
A10: According to the provided content, Dr. Mark Packer serves as the Chief Medical Officer for Cassini Technologies and International Biomedical Devices, Inc., indicating a potential partnership or affiliation between LENSAR LLC and this company.
A1: The text does not explicitly provide the physical address of LENSAR LLC, but it mentions that its industry-leading innovation is guided by the experience and influence of its prestigious Medical Advisory Board.
Q2: What products or services are associated with LENSAR LLC?
A2: Although the provided content primarily focuses on the company's Medical Advisory Board, it does mention that LENSAR LLC offers various products and supplies related to ophthalmology, such as certificates, electronic user manuals, and clinical training materials.
Q3: In which industry is LENSAR LLC operating?
A3: Based on the information provided, it appears that LENSAR LLC operates in the medical device industry, specifically in the field of ophthalmology.
Q4: What services does LENSAR LLC offer to its patients?
A4: The text mentions that LENSAR LLC provides support for patients through various channels, including a contact us page and marketing portal. However, it does not provide detailed information on specific services offered to patients.
Q5: How can one contact LENSAR LLC's customer support or investor relations department?
A5: According to the provided content, investors can contact LENSAR LLC through its Investor Relations section, while customers can reach out to them through the CONTACT US page. However, no phone number is explicitly mentioned.
Q6: What is the composition of LENSAR LLC's Medical Advisory Board?
A6: The text lists 8 members of LENSAR LLC's Medical Advisory Board, including Carlos Buznego, MD; Alan Faulkner, MD; Mitchell A Jackson, MD; Mark Packer, MD, FACS, CPI; and others.
Q7: What is the background and expertise of Dr. Carlos Buznego?
A7: Dr. Carlos Buznego is a Miami-based board-certified ophthalmologist with extensive experience in LASIK, laser cataract, and micro-invasive glaucoma surgery. He has also served as an active staff member at several hospitals and universities.
Q8: What are some notable achievements of Dr. Alan Faulkner?
A8: Dr. Alan Faulkner is a Hawaii-based board-certified ophthalmologist who has been recognized for his expertise in refractive cataract procedures. He has received numerous awards, including being named a Castle Connolly Top Doctor and a Top Doctor in Hawaii by Honolulu Magazine.
Q9: What are some notable achievements of Dr. Mitchell A Jackson?
A9: Dr. Mitchell A Jackson is a board-certified ophthalmologist who has been recognized for his expertise in cataract and refractive surgery. He has received several awards, including the PS250 Premier Surgeon list, OSN300 Refractive Surgeon list, and the 2018 Annual Millennial Award.
Q10: What is LENSAR LLC's relationship with Cassini Technologies?
A10: According to the provided content, Dr. Mark Packer serves as the Chief Medical Officer for Cassini Technologies and International Biomedical Devices, Inc., indicating a potential partnership or affiliation between LENSAR LLC and this company.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
